EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19

User Photo
Cancer-News

1 year
65 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Andrew Krivoshik, MD of @AstellasUS explains insights on EV-103 enfortumab vedotin plus pembrolizumab that was presented at ESMO.
#ESMO2019
Up Next Autoplay
>